95 related articles for article (PubMed ID: 34387762)
1. CDH1 loss promotes diffuse-type gastric cancer tumorigenesis via epigenetic reprogramming and immune evasion.
Zou G; Huang Y; Zhang S; Ko KP; Kim B; Zhang J; Venkatesan V; Pizzi MP; Fan Y; Jun S; Niu N; Wang H; Song S; Ajani JA; Park JI
bioRxiv; 2023 Oct; ():. PubMed ID: 36993615
[TBL] [Abstract][Full Text] [Related]
2. Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease.
Leibold J; Tsanov KM; Amor C; Ho YJ; Sánchez-Rivera FJ; Feucht J; Baslan T; Chen HA; Tian S; Simon J; Wuest A; Wilkinson JE; Lowe SW
Nat Cancer; 2024 Feb; 5(2):315-329. PubMed ID: 38177458
[TBL] [Abstract][Full Text] [Related]
3. Diffuse tumors: Molecular determinants shared by different cancer types.
Li X; Liu D; Wu Z; Xu Y
Comput Biol Med; 2024 Jun; 178():108703. PubMed ID: 38850961
[TBL] [Abstract][Full Text] [Related]
4. Metastatic gastric cancer mouse models.
Ferreira J
Lab Anim (NY); 2024 Feb; 53(2):30. PubMed ID: 38308048
[No Abstract] [Full Text] [Related]
5.
Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of gastric cancer.
El-Rifai W; Powell SM
Semin Radiat Oncol; 2002 Apr; 12(2):128-40. PubMed ID: 11979414
[TBL] [Abstract][Full Text] [Related]
7. Genomic pathobiology of gastric carcinoma.
Katoh H; Ishikawa S
Pathol Int; 2017 Feb; 67(2):63-71. PubMed ID: 28004449
[TBL] [Abstract][Full Text] [Related]
8. Genomic landscape of a mouse model of diffuse-type gastric adenocarcinoma.
Zhang M; Sugita I; Komura D; Katoh H; Shimada S; Inazawa J; Tanaka S; Ishikawa S
Gastric Cancer; 2022 Jan; 25(1):83-95. PubMed ID: 34387762
[TBL] [Abstract][Full Text] [Related]
9. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
10. Cooperativity of E-cadherin and Smad4 loss to promote diffuse-type gastric adenocarcinoma and metastasis.
Park JW; Jang SH; Park DM; Lim NJ; Deng C; Kim DY; Green JE; Kim HK
Mol Cancer Res; 2014 Aug; 12(8):1088-99. PubMed ID: 24784840
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of the genomic alterations in human gastric cancer.
Cui J; Yin Y; Ma Q; Wang G; Olman V; Zhang Y; Chou WC; Hong CS; Zhang C; Cao S; Mao X; Li Y; Qin S; Zhao S; Jiang J; Hastings P; Li F; Xu Y
Int J Cancer; 2015 Jul; 137(1):86-95. PubMed ID: 25422082
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations in gastric cancers discovered via whole-exome sequencing.
Zhang J; Qiu W; Liu H; Qian C; Liu D; Wang H; Hu N; Tang YT; Sun J; Shen Z
BMC Cancer; 2018 Dec; 18(1):1270. PubMed ID: 30567531
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model.
Rotkrua P; Shimada S; Mogushi K; Akiyama Y; Tanaka H; Yuasa Y
Br J Cancer; 2013 Mar; 108(4):932-40. PubMed ID: 23385731
[TBL] [Abstract][Full Text] [Related]
14. Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations.
Katoh H; Ishikawa S
J Hum Genet; 2021 Sep; 66(9):887-899. PubMed ID: 34267306
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer.
Smyth EC; Nilsson M; Grabsch HI; van Grieken NC; Lordick F
Lancet; 2020 Aug; 396(10251):635-648. PubMed ID: 32861308
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
